This site is intended for Healthcare Professionals only.

Search here...
News

Supply Disruption Alert: Dexamethasone 0.1% (Maxidex) 5ml eye drops

By: PB Staff Writer

Date:

Share post:

The Department of Health and Social Care (DHSC) has issued a medicine supply disruption alert for Dexamethasone 0.1% (Maxidex) 5ml eye drops.
Dexamethasone 0.1% (Maxidex®) eye drops, indicated for the treatment of non-infectious inflammatory conditions affecting the anterior segment of the eye, will be in short supply until early August 2021 due to a manufacturing issue.
The 10ml pack size has recently been discontinued and is no longer available. In order to conserve remaining stock, Novartis Pharmaceuticals UK LTD are supplying directly to customers on an allocation basis; however this supply will not meet national demand.
As a result, all patients who are on long term Maxidex® 0.1% will need to be reviewed and switched onto either a dexamethasone 0.1% preservative free preparation or an alternative product until the resupply date.

Organisations who already hold accounts with Novartis can place orders directly via Electronic Data Interchange (EDI), email or telephone.

Previous article
Zydus Cadila gets regulator nod to market its generic cancer drug in US
Next article
IT provision for CPCS changes from Oct 1
PB Staff Writer
PB Staff Writerhttp://www.pharmacy.biz

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Digital Archive
Subscribe Now

Related articles

Features

Pharmacy First service: Two Numark members share their experiences

Lack of cooperation from GP surgeries stalling the uptake of Pharmacy First service in some areas  The nationwide implementation...
Uncategorized

A 5 year analysis: Rural pharmacy closures outpace openings

Findings call for more attention to rural pharmacy as only 8 opened in 2023 across the UK  The Department...
News

33 % rise in women seeking perinatal mental health support since 2022

One in five new and expectant mothers may be affected by perinatal mental health conditions In a significant uptick...
Features

UK GDP Association Delivers Affordable GDP Consultancy for Small Businesses

“We want to help plug the gap where current consultancies fail these smaller businesses, and ultimately benefit UK...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Pharmacy First service: Two Numark members share their experiences

Features 0
Lack of cooperation from GP surgeries stalling the uptake...

A 5 year analysis: Rural pharmacy closures outpace openings

Uncategorized 0
Findings call for more attention to rural pharmacy as...

33 % rise in women seeking perinatal mental health support since 2022

News 0
One in five new and expectant mothers may be...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

NHS to address workforce shortage by recruiting 2,000 doctors from India

News 0
The shortage of doctors in the country is attributed...

LloydsPharmacy confirms exit from the high street

News 0
The chain has closed four stores and sold all...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc

This site is intended for Healthcare Professionals only.